Back to Search Start Over

The close resemblance between patients with severe alopecia areata and those with cancer: What hair tells us about wellness or grave illness.

Authors :
Craiglow BG
Borges KA
King BA
Source :
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. e125-e126. Date of Electronic Publication: 2021 Oct 23.
Publication Year :
2022

Abstract

Competing Interests: Conflicts of interest Dr King has served on advisory boards, is a consultant, and/or is a clinical trial investigator for AbbVie, Aclaris Therapeutics, Inc, AltruBio Inc, Almirall, Arena Pharmaceuticals, Bioniz Therapeutics, Bristol-Meyers Squibb, Concert Pharmaceuticals, Inc, Dermavant Sciences, Inc, Eli Lilly and Company, Incyte Corp, LEO Pharma, Otsuka/Visterra, Inc, Pfizer, Inc, Regeneron, Sanofi Genzyme, TWi Biotechnology, Inc, and Viela Bio, and is on speaker bureaus for Pfizer Inc, Regeneron, and Sanofi Genzyme. Dr Craiglow has received honoraria and/or fees from Aclaris, Arena Pharmaceuticals, Eli Lilly, Regeneron, Sanofi Genzyme, and Pfizer. Author Borges has no conflicts of interest to declare.

Details

Language :
English
ISSN :
1097-6787
Volume :
86
Issue :
3
Database :
MEDLINE
Journal :
Journal of the American Academy of Dermatology
Publication Type :
Editorial & Opinion
Accession number :
34699912
Full Text :
https://doi.org/10.1016/j.jaad.2021.10.031